North America Cardiovascular Devices Market – Size, Outlook, Trends, and Forecast (2024 – 2032)

Cardiovascular devices are used to treat diseases related to the cardiovascular system. Cardiovascular devices are also known as cardiology devices which are used to monitor the functioning of the CVS (Cardiovascular System). Generally, cardiology field includes treatments for heart failure, electrophysiology, coronary artery disease, and others. These medical devices are used to identify the heart conditions, pathologic heart function. Electrophysiology procedures include ECG, Cardiac Monitoring, and others.

North America Cardiovascular Devices Market Segments Size & Growth:

North America Cardiovascular devices market is projected to reach approximately USD XX Billion by 2024, at a CAGR of XX% from XX Billion in 2017 during the forecast period. The key attributes promoting the cardiovascular devices market growth are growing geriatric population, high preference of minimally invasive procedures, and rising prevalence of cardiovascular disease. Technical innovations and advancements in the cardiovascular devices have made a major impact on the North America cardiovascular devices market. Cardiovascular disease is the major cause of all the deaths. To reduce the time to hemostasis, to enable early ambulation, and to improve patient comfort these medical devices are implemented. Cardiac monitoring refers to the continuous monitoring of the heart activity and has to make an assessment relative to the patient’s cardiac rhythm. It generally includes electrocardiography. By considering the reports of World Health Organization 19 Million people across the globe are died in 2012, due to CVD (Cardiovascular Disease), and around 21 Million people are estimated to die by 2024. In United States region nearly 65% of the people aged above 65 years are having the CVD problem. Growing prevalence of cardiovascular diseases, augmenting geriatric population, and obese population is also the factors contributing to the cardiovascular diagnostic and monitoring devices market, which holds the largest market share across the globe. Historically, the FDA and doctors have recommended that pacemaker patients should not undergo an MRI (Magnetic Resource Imaging). Traditional pacemakers are not compatible with MRI, due to the harmful interaction between the device and the electromagnetic field.

North America Cardiovascular Devices Market Segments Share:

North America Cardiovascular Devices Market is segmented by product type which comprises of Cardiac Rhythm Management (CRM), Cardiac Monitoring Devices, Cardiac Surgery Devices, interventional cardiology, peripheral vascular devices, plaque modification devices, and flow alteration devices. External defibrillators can be used as emergency life-saving, with the advent of the sudden heart attack. Rising incidence of sudden heart attacks is propelling the market growth for CRM devices in the United States. Due to saturation of pacemakers implementation will witness a slight decline in the overall CRM devices market share. By procedure, the market is segmented into minimally invasive heart surgery, open heart surgery, heart valve repair or replacement, and angioplasty. By technology, the market is further classified into cardiopulmonary bypass products, bioresorbable stents, and cardiac assist devices. By end-users and applications, the market is further divided into segments. By application cardiac arrhythmia held the highest market share owing to the high prevalence of cardiac arrhythmia. By Geography, North America holds the largest market share and shows the dominance of the overall cardiovascular devices market, due to high implementation and high adoption rate for advanced surgical treatments and presence of a large size target patient pool.

North America Cardiovascular Devices Market Trends:

• Abbott collaborated with St. Jude Medical and launched the world’s smallest, long-lasting wireless MRI Pacemaker which provides ten years device longevity and assists in monitoring patient disease status and performance with automatic remote monitoring.
• Boston Scientific released most advanced pacemakers ACCOLADE and ESSENTIO, which offers the assurance of Automatic Daily Monitoring to improve the patient compliance and to enable earlier intervention.

North America Cardiovascular Devices Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Europe Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major key players in the North America Cardiovascular Devices Market are:

• Abbott Laboratories
• Boston Scientific Corporation
• Arrow International, Inc.
• Jude Medical
• Medtronic
• GE Healthcare
• SIEMENS Healthcare

Along with these companies, there were many other companies considered/cited in the report while analysing the North America Cardiovascular Devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.